Chronic lymphocytic leukemia (b-CLL) and immunocytoma (LP-IC): Clinical and prognostic relevance of this distinction

Leukemia and Lymphoma

Volumn 5, Issue S1, 1991, Pages 161-173

  Engelhard, M ^a   Brittinger, G ^a   Heinz, R ^a   Theml, H ^a   Bartels, H ^a   Binder, T ^a   Fulle H H ^a   Gerhartz, H ^a   Gunzer, U ^a   Ludwig, F ^a   Ludwig, W D ^a   Nowicki, L ^a   Oertel, J ^a   Pees, H W ^a   Pralle, H ^a   Ruhl U ^a   Schilling, Ch V ^a   Spann, W ^a   Szeimies, U ^a   Wetzel, H J ^a   Zwingers, T ^a   Feller, A C ^a   Stein, H ^a   Lennert, K ^a   more..

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Chronic lymphocytic leukemia; Immunocytoma; Low grade malignant; Lymphocytic lymphoma; Non Hodgkin lymphoma

Indexed keywords

AGE; BONE MARROW; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GENDER; HUMAN; IMMUNOCYTOMA; IMMUNOHISTOLOGY; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; NONHODGKIN LYMPHOMA; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

EID: 0026341608     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199109103400     Document Type: Article

References (39)

1. The histopathology of malignant lymphoma
2. Updated Kiel classification for lymphomas
3. Histological and immunohistochemical differences between B-CLL and LP-immunocytoma
4. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia
5. Clonal chromosome abnormalities in patients with Aldenström’s and CLL-associated macroglobulinemia: significance of trisomy 12
6. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications
7. Chronic lymphocytic leukemia: new insights into biology and therapy
8. (Kiel Lymphoma Study Group) Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas: results of a prospective multicenter study by the Kiel Lymphoma Study Group
9. Klinische und prognostische Relevanz der Kiel-Klassifikation der Non-Hodgkin-Lymphome
10. Report of the committee on Hodgkin’s disease staging classification
11. Clinical staging of chronic lymphocytic leukemia
12. Chronic lymphocytic leukaemia: proposals for a revised prognostic staging system. Report from the International Workshop on CLL
13. Biweekly chlorambucil treatment of chronic lymphocytic leukemia
14. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophsphamide, vincristine, and prednisone
15. Non-parametric estimation from incomplete observations
16. Evaluation of survival data and two new rank order statistics arising in its consideration
17. Regression models and life tables
18. Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients
19. Bone marrow biopsy in chronic lymphocytic leukaemia
20. B-chronic lymphocytic leukemia. Disease progression in 150 untreated stage A and B patients as predicted by bone marrow pattern
21. Lymph node biopsy in chronic lymphocytic leukemia: prognostic significance of histopathological, morphometry and immunohistological findings
22. Hereogeneity of CLL: high CD 23 antigen and αIFN receptor expression are features of favourable disease and of cell activation
23. CD 23 antigen expression in CLL
24. Lack of correlation between cell surface activation antigen expression and clinical stage in B-CLL
25. B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features
26. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria
27. Comparison of the (A, B, C) staging and the Rai’s staging from a large prospective series (935 patients)
28. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients
29. A randomized clinical trial of chlarambucil versus COP in stage B chronic lymphocytic leukemia
30. Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia
31. Lymphoplasmacytoid and small cell centrocytic non-Hodgkin’s lymphoma—a retrospective analysis from St. Bartholomew’s Hospital 1972–1986
32. The treatament of indolent lymphomas: watchful waiting v aggressive combined modality treatment
33. A randomized prospective comparison of chemotherapy to total body irradiation as initial treatment for the indolent lymphoproliferative diseases
34. Risikoadaptierte Behandlung von Immuno-zytomen
35. Chlorambucil/prednisone versus CHOP in symptomatic chronic lymphocytic leukemia of B-CLL type
36. 2
37. Prognostic factors in chronic lymphocytic leukaemia: The importance of age, sex and response to treatment in survival
38. Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases